Pharma Braces As UK Launches New Talks On Branded Drug Prices
This article was originally published in The Pink Sheet Daily
Executive Summary
The UK Department of Health has launched an open three-month consultation seeking views on proposals it came up with on how prices of branded NHS medicines should be determined and how the statutory arrangement and its voluntary Pharmaceutical Price Regulation Scheme should be coordinated.